Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cegereal, the French Core Office REIT lets 4,200 sq.m in the Arcs de Seine building

PRESS RELEASE
Paris ­- January 13, 2015 - 8:30 a.m.
Permanent information

Cegereal has signed two new six-year leases on 4,200 square meters of office space in the Arcs de Seine building, raising the property's occupancy rate to 97%.

The new Arcs de Seine tenants are:

  • Amgen, the U.S.-based, Nasdaq-listed biopharmaceutical research, development and marketing company, which will occupy 2,800 sq.m of space (D&B rating: 1).
  • Exclusive Networks, a French provider of innovative IT security, storage and networking solutions, set to occupy 1,400 sq.m of space (D&B rating: 1).

Arcs de Seine is located on the banks of the Seine on Quai du Point du Jour in Boulogne-Billancourt. The property was entirely renovated in 2012. Arcs de Seine is the fourth office building in France to earn both HQE Exploitation and BREEAM In-Use International Very Good environmental certification.

In carrying out the above transactions, Cegereal was advised by Commerz Real on asset management, Cushman & Wakefield on marketing and Clifford Chance on legal matters.

About Cegereal
Listed on Euronext Paris since 2006, in compartment B, Cegereal invests in very large prime office properties located on the outskirts of Paris. The portfolio's appraisal value, as estimated by independent valuers DTZ Eurexi as of December 31, 2013, is €900 million (replacement value). www.cegereal.com

Upcoming events

February 13, 2015 2014 annual results (before start of trading)
April 15, 2015 Annual Shareholders' Meeting

For more information, contact:

 

Investor Relations
Raphaël Tréguier
+33 1 42 25 76 36
raphael.treguier@cegereal.com
 

Media Relations
Aliénor Miens
+33 1 53 32 84 77
alienor.miens@citigate.fr



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cegereal SA via Globenewswire

HUG#1886281
Tags: